# Backline Treatment of Advanced Hepatocellular Carcinoma With Palbociclib

> **NCT06478927** · NA · RECRUITING · sponsor: **Henan Cancer Hospital** · enrollment: 22 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Palbociclib capsules

## Key facts

- **NCT ID:** NCT06478927
- **Lead sponsor:** Henan Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-15
- **Primary completion:** 2026-01-15
- **Final completion:** 2027-01-15
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2024-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06478927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06478927, "Backline Treatment of Advanced Hepatocellular Carcinoma With Palbociclib". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT06478927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*